The US Food and Drug Administration (FDA) has granted marketing authorisation for LumiThera’s Valeda Light Delivery System to ...

Astellas has announced the withdrawal of its MAA for ACP from the EMA to treat geographic atrophy (GA) secondary to AMD.

to develop compounds to treat dry age-related macular degeneration (AMD) and Stargardt disease - both blindness-causing diseases. The team's work has led to the discovery of an advanced ...

Science Corporation's retinal implant allowed some people who lost their central vision to read, play cards, and recognize ...

Age-related macular degeneration, or AMD, is a prevalent eye disorder that affects millions globally. This condition can drastically impair vision and make daily tasks much more difficult.

or advanced dry age-related macular degeneration (AMD). Bisretinoids are by-products of the visual cycle, which is dependent on the supply of vitamin A (retinol) to the eye. Tinlarebant works by ...

The study was designed to demonstrate PRIMA’s safety and efficacy to reach European market approval (CE mark). PRIMA, owned ...

These devices ... for Age-related Macular Degeneration.” American Printing House for the Blind (APH), Connect Center, VisionAware: “Coping with Geographic Atrophy, the Advanced Stage of ...

In final guidance NICE said trials have shown Novartis' Beovu has similar efficacy in wet advanced macular degeneration (AMD) to rival Eylea (aflibercept) from Bayer/Regeneron and Novartis ...